| |
TTD
Drug ID:
DAP001402
| Drug
Information |
| Name | Mitomycin C | | Synonyms | D00208; BSPBio_001267; KBio2_005743; KBio3_001073; CBiol_001927; Mutamycin; CHEBI:27504; BRD-K59670716-001-02-6; Mitomycine [INN-French]; Mitomycinum C; Mytozytrex; Bio1_001191; Ametycin; KBio2_000607; M4287_SIGMA; C06681; CHEMBL105; 50-07-7; Mitamycin; NSC 26980; C15H18N4O5; HMS1362O09; LS-136; Mitomycin C (JP15); Mitomycine; KBioSS_000607; UNII-50SG953SK6; 74349-48-7; Mitomycin C from Streptomyces caespitosus; NSC-26980; AC1L1L1Q; Ametycine; Mitomycin [USAN:INN:BAN]; CID5746; mitomycin C; EINECS 200-008-6; M0440_SIGMA; Mitomycin; Mitomycyna C; Mitomicina [INN-Spanish]; Muamycin; HMS1792O09; Mitomycinum; Mitomycinum [INN-Latin]; Bio1_000213; Bio1_000702; Mit-C; CCRIS 414; KBio2_003175; Muamycin (TN); Ambotz50-07-7; MLS001332654; Mitomycin (USP/INN); DB00305; 1404-00-8; M0503_SIGMA; Mitomycin C, Streptomyces caespitosus, Carrier-Free; 7481-68-7; Mitomycin-C; SMP1_000307; Mito-C; Mitozytrex; Mytomycin; HMS1990O09; 7-Amino-9alpha-methoxymitosane; MMC; Mitomycins; Mitocin C; NCI-C04706; Mitomycyna C [Polish]; HMS2089F16; SMR000058401; Mitomycin (TN); Mitomicina; MolPort-003-938-644; Mitocin-C; NCGC00163468-02; RCRA waste number U010; AI3-26199; Bio2_000464; HSDB 3239; Mitomycin C, Streptomyces caespitosus; nchembio.559-comp7; RCRA waste no. U010; Bio2_000944; IDI1_002219; LS-173087; KBio3_001074; KBioGR_000607; 144085-53-0 | | Indication | Cancers | Approved [1] | | Structure |
Click to save drug structure in 3D MOL format
Click to save drug structure in 2D MOL format | | Therapeutic Class | Antineoplastic Agents | | CAS Number | CAS 50-07-7 | | Formular | C15H18N4O5 | | PubChem Compound ID | CID 5746. | | PubChem Substance ID | SID 8906. | | ChEBI | 27504; | | SuperDrug ATC ID | L01DC03; | | SuperDrug CAS ID | 000050077; | | Target | DNA |  | Adduct | [2] | | Ref 1 | Natural products as sources of new drugs over the last 25 years. J Nat Prod. 2007 Mar;70(3):461-77. Epub 2007 Feb 20. To Reference | | Ref 2 | Structural studies of atom-specific anticancer drugs acting on DNA. Pharmacol Ther. 1999 Sep;83(3):181-215. To Reference |
Welcome
to sign our Guestbook.
If you
find any error in data or bug in web service, please kindly report it
to Dr.
Zhu.
Dr.
Chen Yuzong
Deputy Director of Center
for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore
All rights reserved.
|
|